medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2006, Número 4

<< Anterior Siguiente >>

Rev Invest Clin 2006; 58 (4)


Hipotiroidismo neonatal: fisiopatogenia, aspectos moleculares, metabólicos y clínicos

Solis JC, Valverde C

Idioma: Español
Referencias bibliográficas: 119
Paginas: 318-334
Archivo PDF: 386.74 Kb.


RESUMEN

Este trabajo revisa algunos aspectos del conocimiento actual sobre la fisiopatogenia, los hallazgos clínicos y el diagnóstico bioquímico y molecular del hipotiroidismo neonatal (HNe). El término HNe denota un conjunto de entidades clínicamente pleomórficas, que invariablemente cursan con una disminución en el aporte; o bien, en la disponibilidad celular y/o en la respuesta a las hormonas tiroideas (HT) durante la etapa perinatal. Las HT o yodotironinas son indispensables para la morfogénesis y maduración funcional normal de prácticamente todos los tejidos en el organismo, y su participación es crucial en el caso del sistema nervioso. La información actual permite realizar una clasificación del HNe tanto en términos etio y fisiopatogénicos, como en el contexto del substrato genético que los determina. Así, se reconocen tres grandes tipos de HNe: el endémico, el transitorio y el esporádico. Este último grupo de HNe incluye los defectos hipotálamo hipofisiarios, los trastornos ontogenéticos o disgenesias tiroideas, la resistencia periférica a las HT y las dishormonogénesis. Por otra parte, en la comunidad internacional existe una creciente preocupación por la contaminación ambiental debida a organohalógenos antropogénicos. Estos compuestos han mostrado su potencial como agentes distiroideos en animales de experimentación y en algunos estudios clínicos. En México, tanto la distribución geográfica y prevalencia del HNe, como la deficiencia de yodo y otros micronutrimentos en la dieta, se han analizado de manera esporádica y no sistemática. Aunque incompleta, la información disponible sugiere que en nuestro país la prevalencia de HNe es sensiblemente mayor que la reportada mundialmente. Contar con información completa y confiable acerca de estos aspectos no es trivial, puesto que su conocimiento permitirá establecer políticas razonadas de salud pública para identificar, diagnosticar y tratar oportunamente el padecimiento; así como para prevenir y erradicar el HNe endémico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Gómez VE, Bolaños F, Valverde RC. Tiroides. En: Malacara JM, García VM, Valverde RC (Eds.). Fundamentos de endocrinología. México: Salvat; 1990.

  2. Brent GA. Tissue-specific sctions of thyroid hormone: insights from animal models. Rev Endocr Metab Disord 2000; 1(1): 27-33.

  3. Anderson GW, Mariash CN, Oppenheimer JH. Molecular actions of thyroid hormone. En: Braverman LE, Utiger RD (eds.). The thyroid: a fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, p. 977-83.

  4. Feng X, Jiang Y, Meltzer P, et al. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol 2000; 14(7): 947-55.

  5. Yen PM. Cellular action of thyroid hormone. Chapter 3. The thyroid and its diseases- Book chapters. 2003 (fecha de acceso: febrero 2006). Disponible en: http://www.thyroidmanager.org/Chapter3/3d-frame.htm

  6. Bernal J, Guadaño-Ferraz A, Morte B. Perspectives in the study of thyroid hormone action on brain development and function. Thyroid 2003; 13(11): 1005-12.

  7. Chidakel A, Mentuccia D, Celi FS. Peripheral metabolism of thyroid hormone and glucose homeostasis. Thyroid 2005; 15(8): 899-903.

  8. Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 1999; 50(2): 149-55.

  9. New England congenital hypothyroidism collaborative. Correlation of cognitive test scores and adequacy of treatment in adolescents with congenital hypothyroidism. J Pediatr 1994; 124(3): 383-7.

  10. Frieden E. The chemical elements of life. Sci Am 1972; 227: 52-60.

  11. Mertz W. The essential trace elements. Science 1981; 213: 1332-8.

  12. Bloomfield MM, Stephens LJ. Chemistry and the living organisms. New York: John Wiley & Sons; 1996.

  13. Gribble GW. Naturally occurring organohalogen compounds. Accts Chem Res 1998; 31: 141-52.

  14. Emsley J. Nature’s building blocks. New York: Oxford University Press; 2001.

  15. Valverde-R C, Orozco A, Becerra A, et al. Halometabolites and cellular dehalogenase systems: an evolutionary perspective. Int Rev Cytol 2004; 234: 143-99.

  16. Gribble GW. The diversity of naturally produced organohalogens. Chemosphere 2003; 52: 289-97.

  17. Burman KD, Wartofsky L. Iodine effects on the thyroid gland: biochemical and clinical aspects. Rev Endocr Metab Disord 2000; 1(1): 19-25.

  18. Larsen PR, Davies TF, Schlumberger MJ, Hay ID. Thyroid physiology and diagnostic evaluation of patients with thyroid disorder. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds.). Williams textbook of endocrinology. Philadelphia: Saunders; 2003, p. 331-73.

  19. Pintar JE. Normal development of the hypothalamic-pituitarythyroid axis. In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, p. 7-19.

  20. Davies TF, Ando T, Lin RY, et al. Thyrotropin receptor-associated diseases: From adenomata to Graves disease. J Clin Invest 2005; 115(8): 1972-83.

  21. Missero C, Cobellis G, De Felice M, et al. Molecular events involved in differentiation of thyroid follicular cells. Mol Cell Endocrinol 1998; 140(1-2): 37-43.

  22. Moore KL. Aparato branquial, cabeza y cuello. En: Moore KL (ed.). Embriología clínica. México: Interamericana; 1989, pp. 187-227.

  23. Radetti G, Zavallone A, Gentili L, et al. Foetal and neonatal thyroid disorders. Minerva Pediatr 2002; 54(5): 383-400.

  24. Dunn JT, Dunn AD. Update on intrathyroidal iodine metabolism. Thyroid 2001; 11(5): 407-14.

  25. Kim PS, Arvan P. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: Disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev 1998; 19(2): 173-202.

  26. Carrasco N. Thyroid iodide transport: the Na+/I- symporter (NIS). In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 52-61.

  27. Taurog AM. Hormone synthesis: Thyroid iodine metabolism. In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 61-85.

  28. Dunn JT, Dunn AD. Thyroglobulin: Chemistry, biosynthesis and proteolysis. In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 91-104.

  29. Andersson HC, Kohn LD, Bernardini I, et al. Characterization of lysosomal monoiodotyrosine transport in rat thyroid cells. Evidence for transport by system H. J Biol Chem 1990; 265(19): 10950-4.

  30. Snyder PJ. The pituitary in hypothyroidism. In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 811-14.

  31. Silva EJ. Catecholamines and the sympathoadrenal system in hypothyroidism. In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 820-3.

  32. Diekman T, Lansberg PJ, Kastelein JJ, et al. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Inter Med 1995; 155(14): 1490-5.

  33. Franklyn JA. Metabolic changes in hypothyroidism. In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 833-6.

  34. Foley TP. Congenital hypothyroidism. Hypothyroidism in infants and children. In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 977-83.

  35. Grant DB, Smith I, Fuggle PW, et al. Congenital hypothyroidism detected by neonatal screening: Relationship between biochemical severity and early clinical features. Arch Dis Child 1992; 67(1): 87-90.

  36. Unachak K, Dejkhamron P. Primary congenital hypothyroidism: Clinical characteristics and etiological study. J Med Assoc Thai 2004; 87(6): 612-7.

  37. LaFranchi S. Congenital hypothyroidism: Etiologies, diagnosis, and management. Thyroid 1999; 9(7): 735-40.

  38. Brown R, Larsen PR. Thyroid gland development and disease in infancy and childhood. Chapter 15. The thyroid and its diseases- Book chapters. 2005 (fecha de acceso: febrero 2006). Disponible en: http://www.thyroidmanager.org/Chapter15/15-frame.htm

  39. Rovet JF, Ehrlich RM. Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1995; 126(3): 380-6.

  40. Glorieux J, Dussault J, Van Vliet G. Intellectual development at age 12 years of children with congenital hypothyroidism diagnosed by neonatal screening. J Pediatr 1992; 121(4): 581-4.

  41. Dussault JH, Coulombe P, Laberge C, et al. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr 1975; 86: 670-4.

  42. Poder-Ejecutivo-Federal. Norma técnica No 321 para la prevención del retraso mental producido por hipotiroidismo congénito. México: Gobierno Constitucional de los Estados Unidos Mexicanos. México: Diario Oficial de la Federación 1988; 14: 88-90.

  43. Vela-Amieva M, Hernández-Osorio C, Gamboa-Cardiel S, et al. Hipertirotropinemia en recién nacidos Mexicanos. Salud Pública Mex 2003; 45(4): 269-75.

  44. Moreno JC, De Vijlder JJ, Vulsma T, et al. Genetic basis of hypothyroidism: recent advances, gaps and strategies for future research. Trends Endocrinol Metab 2003; 14(7): 318-26.

  45. Hetzel BS. Iodine Deficiency Disorders (IDD), and their eradication. Lancet 1983; 2: 1126-9.

  46. World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination. A guide for programme managers. Second edition, 2001; WHO/NHD/01.1.

  47. Delange FM, Hetzel B. The iodine deficiency disorders. Chapter 20. The thyroid and its diseases - Book chapters. 2005 (fecha de acceso: febrero 2006). Disponible en: http://www.thyroidmanager.org/Chapter20/20-frame.htm

  48. Kavishe FP. Iodine deficiency disorders. In: Sadler MJ, Strain JJ, Caballero B (eds.). Encyclopedia of Human Nutrition. Vol. 3. London: Academic Press; 1999, pp. 1146-53.

  49. Vitti P, Rago T, Aghini-Lombardi F, et al. Iodine deficiency disorders in Europe. Public Health Nutrition 2001; 4(2B): 529-35.

  50. World Health Organization. Iodine deficiency disorders. WHO fact sheet No 121. Geneva, Switzerland: WHO; 1996.

  51. Hetzel BS. Eliminating iodine deficiency disorders: The role of the international council in the global partnership. Bull World Health Organ 2002; 80(5): 410-12.

  52. WHO, UNICEF, ICCIDD. Progress towards elimination of iodine deficiency disorders. Geneva: World Health Organization; 1999.

  53. Vela M, Gamboa S, Loera-Luna A, et al. Neonatal screening for congenital hypothyroidism in México: experience, obstacles, and strategies. J Med Screen 1999; 6: 77-9.

  54. Vela-Amieva M, Gamboa-Cardiel S, Pérez-Andrade ME, et al. Epidemiología del hipotiroidismo congénito en México. Salud Pública Mex 2004; 46(2): 141-8.

  55. Delange FM. Endemic cretinism. In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 743-54.

  56. Martínez-Salgado H, Castaneda-Limones R, Lechuga-Martín del Campo D, et al. Deficiencia de yodo y otros posibles bociógenos en la persistencia del bocio endémico en México. Gac Méd Méx 2002; 138(2): 149-56.

  57. Vásquez-Garibay EM, Romero-Velarde E, Nápoles-Rodriguez F, et al. Prevalencia de deficiencia de hierro y yodo, y parasitosis en niños de Arandas, Jalisco, México. Salud Pública Mex 2002; 44(3): 195-200.

  58. Klein RZ, Mitchell ML. Hypothyroidism in infants and children. In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 973-7.

  59. Fugazzola L, Persani L, Mannavola D, et al. Recombinant human TSH testing is a valuable tool for differential diagnosis of congenital hypothyroidism during L-thyroxine replacement. Clin Endocrinol 2003; 59(2): 230-6.

  60. De Vijlder JJ, Vulsma T. Hereditary metabolic disorders causing hypothyroidism. In: Braverman LE, Utiger RD (Eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 733-42.

  61. Kopp P. Pendred’s syndrome and genetic defects in thyroid hormone synthesis. Rev Endocr Metab Disord 2000; 1: 109-21.

  62. McKusick VA. Mendelian inheritance in man. A catalog of human genes and genetic disorders. Baltimore: Johns Hopkins University Press; 1998.

  63. Vono-Toniolo J, Kopp P. Thyroglobulin gene mutations and other genetic defects associated with congenital hypothyroidism. Arq Bras Endocrinol Metab 2004; 48(1): 70-82.

  64. Vassart G. TSH receptor mutations and diseases. Chapter 16. The thyroid and its diseases - Book chapters. 2003 (fecha de acceso: febrero 2006). Disponible en: http://www.thyroidmanager.org/Chapter16/16a-frame.htm

  65. Stenson PD, Ball EV, Mort M, et al. Human gene mutation database (HGMD): 2003 update. Hum Mutat 2003; 21(6): 577-81 (véase también: http://www.hgmd.cf.ac.uk/).

  66. Macchia PE, De Felice M, Di Lauro R. Molecular genetics of congenital hypothyroidism. Curr Opin Genet Dev 1999; 9(3): 289-94.

  67. De Felice M, Ovitt C, Biffali E, et al. A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 1998; 19(4): 395-8.

  68. Tell G, Pellizzari L, Esposito G, et al. Structural defects of a Pax8 mutant that give rise to congenital hypothyroidism. Biochem J 1999; 341(Pt 1): 89-93.

  69. Macchia PE. Recent advances in understanding the molecular basis of primary congenital hypothyroidism. Mol Med Today 2000; 6(1): 36-42.

  70. Gillam MP, Kopp P. Genetic regulation of thyroid development. Curr Opin Pediatr 2001; 13(4): 358-63.

  71. Kopp P. Perspective: Genetic defects in the etiology of congenital hypothyroidism. Endocrinology 2002; 143(6): 2019-24.

  72. Refetoff S. Resistance to thyroid hormone. In: Braverman LE, Utiger RD (eds.). The thyroid: A fundamental and clinical text. New York: Lippincott Williams & Wilkins; 2000, pp. 1028-43.

  73. Refetoff S. Resistance to thyroid hormone. Chapter 16d. The thyroid and its diseases - Book chapters. 2004 (fecha de acceso: febrero 2006). Disponible en: http://www.thyroidmanager.org/Chapter16/16d-frame.htm

  74. Friesema E, Grueters A, Halestrap A. et al. Mutations in a thyroid hormone transporter in patients with severe psicomotor retardation and high serum T3 levels. Thyroid 2003; 13(7): 672.

  75. Dumitrescu AM, Liao XH, Best TB, et al. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004; 74(1): 168-75.

  76. Friesema ECH, Jansen J, Visser TJ. Thyroid hormone transporters. Biochem Soc Trans 2005; 33(1): 228-32.

  77. Jansen J, Friesema ECH, Milici C, Visser TJ. Thyroid hormone transporters in health and disease. Thyroid 2005; 15(8): 757-68.

  78. Weiss RE, Refetoff S. Resistance to thyroid hormone. Reviews in Endocrine and Metabolic Disorders 2000; 1(1): 97-108.

  79. Refetoff S. Defects of thyroid hormone transport in serum. Chapter 16c. The thyroid and its diseases - Book chapters. 2004 (fecha de acceso: febrero 2006). Disponible en: http://www.thyroidmanager.org/Chapter16/16c-frame.htm

  80. Yen PM. Thyrotropin receptor mutations in thyroid diseases. Rev Endocr Metab Disorde 2000; 1(1): 123-9.

  81. Davies TF, Ando T, Lin RY, Tomer Y, et al. Thyrotropin receptor-associated diseases: From adenomata to graves disease. J Clin Invest 2005; 115(8): 1972-83.

  82. Spiegel AM. Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 1996; 81(7): 2434-42.

  83. Gillam MP, Kopp P. Genetic defects in thyroid hormone synthesis. Curr Opin Pediatr 2001; 13(4): 364-72.

  84. Rodriguez AM, Perron B, Lacroix L, et al. Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J Clin Endocrinol Metab 2002; 87(7): 3500-3.

  85. Yoshida A, Taniguchi S, Hisatome I, et al. Pendrin is an iodide- specific apical porter responsible for iodide efflux from thyroid cells. J Clin Endocrinol Metab 2002; 87(7): 3356-61.

  86. Franklyn J, Shephard M. Evaluation of thyroid function in health and disease. Chapter 6e. The thyroid and its diseases - Book chapters. 2000 (fecha de acceso: febrero 2006). Disponible en: http://www.thyroidmanager.org/Chapter6/6-text.htm

  87. De Vijlder JJ. Primary congenital hypothyroidism: Defects in iodine pathways. Eur J Endocrinol 2003; 149(4): 247-56.

  88. Suzuki K, Lavaroni S, Mori A, et al. Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci 1998; 95(14): 8251-6.

  89. Suzuki K, Nakazato M, Ulianich L, et al. Thyroglobulin autoregulation of thyroid-specific gene expression and follicular function. Rev Endocr Metab Disord 2000; 1(3): 217-24.

  90. Brix K, Lemansky P, Herzog V. Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells. Endocrinology 1996; 137(5): 1963-74.

  91. Linke M, Jordans S, Mach L, et al. Thyroid stimulating hormone upregulates secretion of cathepsin B from thyroid epithelial cells. Biol Chem 2002; 383(5): 773-84.

  92. Friedrichs B, Tepel C, Reinheckel T, et al. Thyroid functions of mouse cathepsins B, K, and L. J Clin Invest 2003; 111(11): 1733-45.

  93. De Deken X, Wang D, Many MC, et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 2000; 275(30): 23227-33.

  94. Rosenberg IN, Goswami A. Iodotyrosine deiodinase from bovine thyroid. Methods in Enzymology 1984; 107: 488-500.

  95. Solis-S JC, Villalobos P, Orozco A, Valverde-R C. Comparative kinetic characterization of rat thyroid iodotyrosine dehalogenase and iodothyronine deiodinase type 1. J Endocrinol 2004; 181(3): 385-92.

  96. Stanbury JB, Meijer JWA, Kassenaar AAH. The metabolism of iodotyrosines. II. The metabolism of mono- and diiodotyrosine in certain patients with familial goiter. J Clin Endocrinol Metab 1956; 16: 848-61.

  97. Querido A, Stanbury JB, Kassenaar AAH, et al. The metabolism of iodotyrosines. III. Di-iodotyrosine deshalogenating activity of human thyroid tissue. J Clin Endocrinol Metab 1956; 16: 1096-112.

  98. Moreno JC, Keijser R, Aarraas S, et al. Cloning and characterization of a novel thyroidal gene encoding proteins with a conserved nitroreductase domain. J Endocrinol Invest 2002; 25:23.

  99. Gnidehou S, Caillou I, Talbot M, et al. Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site. FASEB 2004; 18: 1574-6.

  100. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000; 343(3): 185-9.

  101. 101.Konrad D, Ellis G, Perlman K. Spontaneous regression of severe acquired infantile hypothyroidism associated with multiple liver hemangiomas. Pediatrics 2003; 112(6): 1424-6.

  102. Huang SA, Fish SA, Dorfman DM, et al. A 21-year-old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase. J Clin Endocrinol Metab 2002; 87(10): 4457-61.

  103. Selva KA, Mandel SH, Rien L, et al. Initial treatment dose of L-thyroxine in congenital hypothyroidism. J Pediatr 2002; 141(6): 786-92.

  104. Cassio A, Cacciari E, Cicognani A, et al. Treatment for congenital hypothyroidism: Thyroxine alone or thyroxine plus triiodothyronine? Pediatrics 2003; 111(5 Pt 1): 1055-60.

  105. Rovet JF, Ehrlich RM, Sorbara DL. Neurodevelopment in infants and preschool children with congenital hypothyroidism: Etiological and treatment factors affecting outcome. J Pediatr Psychol 1992; 17(2): 187-213.

  106. 106.Gottschalk B, Richman RA, Lewandowski L. Subtle speech and motor deficits of children with congenital hypothyroid treated early. Dev Med Child Neurol 1994; 36(3): 216-20.

  107. Rovet JF. Congenital hypothyroidism: long-term outcome. Thyroid 1999; 9(7): 741-8.

  108. Rovet JF.Children with congenital hypothyroidism and their siblings: do they really differ? Pediatrics 2005; 115(1): 52-6.

  109. Hanukoglu A, Perlman K, Shamis I, et al. Relationship of etiology to treatment in congenital hypothyroidism. J Clin Endocrinol Metab 2001; 86(1): 186-91.

  110. Oerbeck B, Sundet K, Kase BF, et al. Congenital hypothyroidism: Influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics 2003; 112(4): 923-30.

  111. Alabbasy AJ, Delbridge L, Eckstein R, et al. Microfollicular thyroid adenoma and congenital goitrous hypothyroidism. Arch Dis Child 1992; 67(10): 1294-5.

  112. Aronson R, Sochett E, Pearl RH, et al. Nodular hyperplasia in treated congenital goitrous hypothyroidism. J Pediatr Endocrinol Metab 1996; 9(6): 613-6.

  113. Hindmarsh PC. Optimization of thyroxine dose in congenital hypothyroidism. Arch Dis Child 2002; 86(2): 73-5.

  114. Hopwood NJ. Treatment of the infant with congenital hypothyroidism. J Pediatr 2002; 141(6): 752-4.

  115. Heyerdahl S, Oerbeck B. Congenital hypothyroidism: Developmental outcome in relation to levothyroxine treatment variables. Thyroid 2003; 13(11): 1029-38.

  116. Osborn DA. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. Cochrane Database Syst Rev 2001; (4): CD001070.

  117. 117.Ogilvy-Stuart AL. Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed 2002; 87(3): F165-F171.

  118. Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr 2001; 139(2): 182-8.

  119. Pauws E, Moreno JC, Tijssen M, et al. Serial analysis of gene expression as a tool to assess the human thyroid expression profile and to identify novel thyroidal genes. J Clin Endocrinol Metab 2000; 85: 1923-7.




2020     |     www.medigraphic.com